Description
Founded in 2009, Seroba Life Sciences is a venture capital firm based in Dublin, Ireland. The firm seeks to invest in the healthcare sector.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Perfuze | 09-Feb-2022 | Early Stage VC | 000.00 | Surgical Devices | Clinical Trials - General | 000000 0'000000 00.0 |
00000 000000000000 | 21-Jul-2021 | 00000 00000 | 000.00 | Drug Delivery | Generating Revenue | 00000 000000000 00.0 |
00000000 | 28-Jun-2021 | 00000 00000 | 00.000 | Surgical Devices | Generating Revenue | 00000000 0000000 |
000000 | 23-Jun-2021 | 00000 00000 | 00000 | Other Devices and Supplies | Generating Revenue | 00000 000000 |
000000 00000000 | 16-Feb-2021 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue/Not Profitable | 0000 0'0000000 00.0 |
0000000000 | 24-Sep-2019 | 00000 00000 | 000.00 | Decision/Risk Analysis | Generating Revenue | 00000000 0000000 |
000000 | 29-Jul-2019 | 00000 00000 | 0000 | Other Devices and Supplies | Generating Revenue | 00000 000000 |
00000 000000000000 | 20-May-2019 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 000000000 00.0 |
Fusion Pharmaceuticals | 25-Mar-2019 | Early Stage VC | 00000 | Drug Discovery | Generating Revenue/Not Profitable | 0000 0'0000000 00.0 |
PQ Bypass | 14-Jan-2019 | Later Stage VC | 0000 | Surgical Devices | Generating Revenue | 000000 0'000000 00.0 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
PQ Bypass | 13-Apr-2021 | Merger/Acquisition | |
000000 00000000000 | 26-Jun-2020 | 000 | 00000 |
0000000000000000 0 | 25-Jun-2020 | 000000000000000000 | 00000 |
0000 000000 | 01-Oct-2019 | 000 00 00000000 | |
0000000 | 30-Jan-2019 | 000000000000000000 | |
000000 00000000000 | 13-Jan-2019 | 0000000000: 000000 | |
000000 | 13-Dec-2018 | 000000000000000000 | |
000000 0000000 000 | 07-Sep-2018 | 000000000000000000 | 00000 |
Biosensia | 13-Jul-2018 | Merger/Acquisition | |
Prexton Therapeutics | 16-Mar-2018 | Merger/Acquisition | 00000 |
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Alan O'Connell Ph.D | Partner | 00 | 0 | 0 | Dublin, Ireland |
Daniel O'Mahony Ph.D | Partner | 00 | 0 | 0 | Dublin, Ireland |
Andrew Duignan | Chief Financial Officer | Dublin, Ireland | |||
Bruno Montanari Ph.D | Partner | 00 | 00 | 0 | Dublin, Ireland |
Jennifer McMahon | Partner | 0 | 0 | 0 | Dublin, Ireland |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
EQT Life Sciences | 3 | 0 |
![]() |
![]() |
|
Earlybird Venture Capital | 0 | 0 |
![]() |
![]() |
|
Enterprise Ireland | 0 | 0 |
![]() |
![]() |
|
Lumira Ventures | 0 | 0 |
![]() |
![]() |
|
SV Health Investors | 0 | 0 |
![]() |
![]() |